Breast Cancer Index (BCI) is a test to help doctors determine the likelihood that certain types of breast cancer will return after five years and whether extended hormonal therapy will benefit the patient.
“When a woman is first diagnosed with estrogen-receptor positive breast cancer, cancer that grows in response to estrogen, we typically perform tests to map out the best course of treatment,” says Carlos Robles, MD, medical oncologist/hematologist, Saint Francis Medical Partner. “These tests use evidence-based data to predict whether the patient will need aggressive treatment. BCI is a new test that can be performed after successful treatment to help us decide what, if any, further treatment is needed.”
“When we learn a patient is at high risk for recurrence after five years, we can continue hormone therapy indefinitely. BCI is another tool in our arsenal we can use to provide the highest quality care for our patients,” says Robles.